| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/03/2009 | EP1768996B1 Variants of group 1 allergens of poaceae with reduced allergenicity and a maintained t-cell reactivity |
| 06/03/2009 | EP1692171B1 Agents modulating the activity of ccrl2 and methods of using the same |
| 06/03/2009 | EP1660135B1 Method of treating hepatocellular carcinoma |
| 06/03/2009 | EP1603938B1 Inclusion bodies as antigens for the oral vaccination of animals against csfv |
| 06/03/2009 | EP1435906B1 Method for producing biologically active products |
| 06/03/2009 | EP1407017B1 Human tumor necrosis factor receptor |
| 06/03/2009 | EP1399472B1 Soluble heterodimeric cytokine receptor |
| 06/03/2009 | EP1362058B1 Comparative ligand mapping from mhc positive cells |
| 06/03/2009 | EP1295943B1 Polypeptides having activity of stimulating neutrophils |
| 06/03/2009 | EP1240200B1 Separation of fibrinogen from plasma proteases |
| 06/03/2009 | EP1131426B1 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides |
| 06/03/2009 | EP1012283B1 Mage-3 peptides presented by hla class ii molecules |
| 06/03/2009 | EP0772677B1 T cell activation |
| 06/03/2009 | CN101448852A Compositions and methods for producing a composition |
| 06/03/2009 | CN101448851A Improved antimicrobial peptides |
| 06/03/2009 | CN101445802A Novel porcine circovirus virus, vaccines and diagnosis agent |
| 06/03/2009 | CN101445800A T1r taste receptors and genes encoding same |
| 06/03/2009 | CN101445557A Cadmium ion antigen and preparation method and application thereof |
| 06/03/2009 | CN101445556A Method for preparing ciprofloxacin immunogen |
| 06/03/2009 | CN101445555A Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 06/03/2009 | CN101445554A Wood frog anticancer peptide and preparation method thereof |
| 06/03/2009 | CN101445553A Paddy drought resistance gene OsSINAT5 and encoding protein and application thereof |
| 06/03/2009 | CN101445552A Rice protein OsOEE3-1, encoding gene and application thereof |
| 06/03/2009 | CN101444624A Medicine for cancer therapy |
| 06/03/2009 | CN100494388C Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 06/03/2009 | CN100494378C Transgenic organism expressing fungal MRP-like ABC transporters |
| 06/03/2009 | CN100494363C Glycooxidase and its application in baking process |
| 06/03/2009 | CN100494344C New biopesticide using gene from erwinia pyrifoliaeWT#3, novel pathogen that affects asian pear trees |
| 06/03/2009 | CN100494213C Process for preparing synergistic factor in artificial blood, nucleotide sequence used thereby |
| 06/03/2009 | CN100493601C Method of protein purification and recovery |
| 06/03/2009 | CA2613075A1 Synthetic antigen mimetics immuno-reactive with rheumatoid arthritis auto-antibodies |
| 06/02/2009 | US7541517 Bacillus thuringiensis CRY9 nucleic acids |
| 06/02/2009 | US7541491 Gene involved in growth-promoting function of acetic acid bacteria and uses thereof |
| 06/02/2009 | US7541452 Monocotyledon promoter sequences for use as tools to enhance heterologous gene expression in plants |
| 06/02/2009 | US7541451 Nucleotide sequences coding green fluorescent proteinfor use as reporter molecules in gene expression and polypeptide analysis |
| 06/02/2009 | US7541450 producing the hybrid proteins comprising a single polypeptide having a target protein with a ligand-dependent intein embedded in the sequence of target proteins; modulation of protein activity; molecular switches |
| 06/02/2009 | US7541449 DNA segment encoding the enzyme inhibitor for therapy of thrombosis, blood disorders; biodrugs; genetic vaccines; monoclonal antibodies; host cells |
| 06/02/2009 | US7541446 Transcriptional activator fusion proteins which comprises both tetracycline controlled transactivator proteins and reverse tetracycline transactivator proteins |
| 06/02/2009 | US7541443 A humanized antibody for use as immunosuppressants, treating or preventing transplant rejection in human patient; drug screening |
| 06/02/2009 | US7541439 Thrombopoietin proteins with improved properties |
| 06/02/2009 | US7541437 Breast cancer resistance protein (BCRP) and the DNA which encode it |
| 06/02/2009 | US7541436 covalently attached to a nonpeptide polyoxyethylene glycol moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells; drugs/polymer conjugates/ as viricides treating Hepatitis-C virus |
| 06/02/2009 | US7541435 Antagonists of cxcr3-binding cxc chemokines |
| 06/02/2009 | US7541434 Polypeptide for a TRP channel family member, TRP-PLIK2, and splice variants |
| 06/02/2009 | US7541433 Transformed plant or fish cells with the isolated polynucleotide; wider array of colors and biochemical features compared to existing wild-type green fluorescent protein |
| 06/02/2009 | US7541432 L-glutamate-gated chloride channel proteins from Rhipicephalus sanguineus |
| 06/02/2009 | US7541431 Cristin/R-spondin ligands active in the Wnt signaling pathway and methods, compositions and kits relating thereto |
| 06/02/2009 | US7541430 Cyclic and linear peptides useful in the treatment of obesity which are specific to one or more melanocortin receptor and which exert a prolonged activity; use of the peptides in therapy and in the manufacture of medicaments |
| 06/02/2009 | US7541429 Comparative ligand mapping from MHC positive cells |
| 06/02/2009 | US7541428 Tumor antigen protein SART-3 and tumor antigen peptides thereof |
| 06/02/2009 | US7541339 Par-2-activating peptide derivative and pharmaceutical composition using the same |
| 06/02/2009 | US7541338 Glial mitogenic factors, their preparation and use |
| 06/02/2009 | US7541337 Methods and compositions for the treatment of peripheral artery disease |
| 06/02/2009 | US7541335 Nogo-receptors and methods of use |
| 06/02/2009 | US7541334 Hybrid peptides modulate the immune response |
| 06/02/2009 | US7541332 reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered; antifungal agents; inhibiting expression of cell wall glycoproteins and preventing pathogens from showing pathogenicity |
| 06/02/2009 | US7541329 Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease |
| 06/02/2009 | US7541328 Coupling proteins to a modified polysaccharide |
| 06/02/2009 | US7541189 complex of a certain ARNT family transcription coupling factor and a certain transcription regulatory factor with ability of exerting a promotive activity on the CME sequence; Down's syndrome |
| 06/02/2009 | US7541183 Growth and differentiation of adult muscle stem cells with activators or inhibitors of Wnt signaling |
| 06/02/2009 | US7541181 Vector carrying a polynucleotide which encodes a GSD polypeptide from Mycobacterium paratuberculosis |
| 06/02/2009 | US7541180 comprising administering to a cells or tissues in vitro; hepatitis C virus (HCV) antigens; dna immunization |
| 06/02/2009 | US7541179 Vector encoding human globin gene and use thereof in treatment of hemoglobinopathies |
| 06/02/2009 | US7541174 Bacterial host cell for the direct expression of peptides |
| 06/02/2009 | US7541164 Mammalian cell culture processes for protein production |
| 06/02/2009 | US7541163 Expression vector comprising nucleotide sequences coding multifunctional protein with viricidal activity |
| 06/02/2009 | US7541158 Canine Tas1r1, Tas1r2, and Tas1r3 receptor genes; screening for compounds that modify the genes' function or activity; modifying taste preferences, ingestive responses, or general behavior of a mammal such as a dog by administering compounds that affect the function or activity of the gene |
| 06/02/2009 | US7541154 GASP1: a follistatin domain containing protein |
| 06/02/2009 | US7541150 Based on correlation between nucleolin cellular plasma membrane expression and presence, aggressiveness of neoplastic cells |
| 06/02/2009 | US7541149 Monoclonal antibody and assay for detecting PIIINP |
| 06/02/2009 | US7541142 Protein useful for diagnosis, cancer therapy |
| 06/02/2009 | US7541139 Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins |
| 06/02/2009 | US7541040 Chimeric molecule for the treatment of th2-like cytokine mediated disorders |
| 06/02/2009 | US7541039 Vaccine delivery; attaching immunogenic determinant of heterologous polypeptide biodrug to the peptidoglycan microparticle on cell wall of a Gram-positive bacterium; improve the binding by treating the cell wall with acid solution to remove protein, lipotechoic, carbohydrates |
| 06/02/2009 | US7541038 Fusogenic, self-propagating blebs as immunogenic compositions |
| 06/02/2009 | US7541036 Human immunodeficiency virus type 1 (HIV-1) matrix (MA or p17) polypeptide capable of inducing anti-p17 antibodies that neutralize the proinflammatory activities of the MA protein |
| 06/02/2009 | US7541035 Immunogenic peptides for the treatment of prostate and breast cancer |
| 06/02/2009 | US7541028 shell portion of biodegradable positively charged chitosan, a core of negatively charged substrate of polyglutamic acid; administer monoclonal antibodies orally in nanoparticles that provide enhanced paracellular permeability, bioavailability, and sustained release |
| 06/02/2009 | US7541027 polyclonal antibodies, monoclonal antibodies, F(ab')2, Fab and single chain Fv; tyrosine at position 1214 in the amino acid sequence of the vascular endothelial growth factor receptor |
| 06/02/2009 | US7541018 Treatment process using somatostatin analogues |
| 06/02/2009 | CA2480564C Novel root-knot nematode-resistance gene and application thereof |
| 06/02/2009 | CA2395364C Model animal with onset of collagen-induced arthritis |
| 06/02/2009 | CA2339089C Cold-adapted equine influenza viruses |
| 06/02/2009 | CA2335937C Azaftig, a proteoglycan for monitoring cachexia and for control of obesity |
| 06/02/2009 | CA2321664C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/02/2009 | CA2274495C Uspa1 and uspa2 antigens of moraxella catarrhalis |
| 06/02/2009 | CA2249351C Novel method of diagnosing and treating gliomas |
| 06/02/2009 | CA2247388C Pharmaceutical composition comprising serum amyloid p component for prophylactic or therapeutic treatment of virus infections and a kit for detecting binding of compositions to virus components |
| 06/02/2009 | CA2235419C Microorganisms and processes for the fermentative preparation of l-cysteine, l-cystine, n-acetylserine or thiazolidine derivatives |
| 06/02/2009 | CA2189947C Use of von willebrand factor and pharmaceutical formulation |
| 06/02/2009 | CA2178208C Purification of vitamin-k dependent proteins by membrane chromatography |
| 06/02/2009 | CA2068863C Particle-mediated transformation of animal tissue cells |
| 05/30/2009 | CA2618374A1 Trimeric collagen scaffold antibodies |
| 05/28/2009 | WO2009067642A2 Removing polypeptides from stool |
| 05/28/2009 | WO2009067639A2 Variants of c-type natriuretic peptide |
| 05/28/2009 | WO2009067580A2 Maize ethylene signaling genes and modulation of same for improved stress tolerance in plants |
| 05/28/2009 | WO2009067569A2 Plants with altered root architecture, related constructs and methods involving genes encoding leucine rich repeat kinase (llrk) polypeptides and homologs thereof |
| 05/28/2009 | WO2009067242A2 Co-crystal of antibody 11f8 fab fragment and egfr extracellular domain and uses thereof |
| 05/28/2009 | WO2009067191A2 Methods and compositions for the treatment of hepatitis c virus (hcv) infection |
| 05/28/2009 | WO2009067177A2 Bone morphogenic protein binding peptide |